Nuvectra to Participate in Morgan Stanley Global Healthcare Conference
August 30 2017 - 4:01PM
Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical
device company, announced today that Scott Drees, Chief Executive
Officer, and Walter Berger, Chief Operating Officer & CFO, are
scheduled to participate at the Morgan Stanley Global Healthcare
Conference in New York, NY.
Event:
Morgan Stanley Global Healthcare
ConferenceDate:
Monday, September 11,
2017
The Company will be participating in one-on-one investor
meetings at the conference and will not make a formal presentation.
If interested in meeting with management, please reach out to Brian
Johnston at bjohnston@theruthgroup.com, or your Morgan Stanley
contact.
About Nuvectra Corporation
NuvectraTM is a neurostimulation company committed to helping
physicians improve the lives of people with chronic neurological
conditions. The Algovita® Spinal Cord Stimulation (SCS) System is
our first commercial offering and is CE marked and FDA approved for
the treatment of chronic intractable pain of the trunk and/or
limbs. Our innovative technology platform also has capabilities
under development to support other indications such as sacral
neuromodulation (SNM) for the treatment of overactive bladder, and
deep brain stimulation (DBS) for the treatment of Parkinson’s
Disease. In addition, our NeuroNexus subsidiary designs,
manufactures and markets leading-edge neural-interface technologies
for the neuroscience clinical research market. Visit the Nuvectra
website at www.nuvectramed.com.
Company Contacts:
Nuvectra Corporation
Walter Berger, COO & CFO
(214) 474-3102
wberger@nuvectramed.com
Jennifer Armstrong, Media Relations
(214) 474-3110
jarmstrong@nuvectramed.com
Investor Contacts:
The Ruth Group
Zack Kubow
(646) 536-7020
zkubow@theruthgroup.com
Brian Johnston
(646) 536-7028
bjohnston@theruthgroup.com
Nuvectra (NASDAQ:NVTR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nuvectra (NASDAQ:NVTR)
Historical Stock Chart
From Apr 2023 to Apr 2024